Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Permanent Cell Line Cell
DISEASE(S): Head And Neck Cancer
SUBMITTER: Donald Wolfgeher
LAB HEAD: Dr. Stephen J Kron
PROVIDER: PXD007188 | Pride | 2019-06-25
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
160107_SPROT_Human_Iso_UP000005640.fasta | Fasta | |||
160208_SvR2_Gel.pptx | Other | |||
160323_SvR_Maxquant_Results.zip | Other | |||
160328_SvR2_proteinGroups_Final.xlsx | Xlsx | |||
170801_SvR.sf3 | Other |
Items per page: 1 - 5 of 79 |
Molecular oncology 20190726 9
Radioresistance is a major hurdle in the treatment of head and neck squamous cell carcinoma (HNSCC). Here, we report that concomitant treatment of HNSCCs with radiotherapy and mevalonate pathway inhibitors (statins) may overcome resistance. Proteomic profiling and comparison of radioresistant to radiosensitive HNSCCs revealed differential regulation of the mevalonate biosynthetic pathway. Consistent with this finding, inhibition of the mevalonate pathway by pitavastatin sensitized radioresistant ...[more]